Ethical Compliance
PIRAMAL PHARMA
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
0.2%
Debt
29.8%
Liquidity
3.2%
Revenue
Debt
Liquidity
0.2%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Services | ₹1,039.96 |
| Sale of Scrap | ₹45.31 |
| Others (insurance Claims, Export Incentives Etc.) | ₹19.44 |
| Pharmaceuticals | ₹7,066.45 |
| Other Income | ₹159.20 |
Questionable
INR Crores
Non Compliant
INR Crores
| interest & other | ₹16.19 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹16.19 |
| Total: | ₹16.19 |
| Total Revenue: | ₹8,346.55 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹16.19
₹8,346.55
= 0.2%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
